RGS Fundamental Analysis - REGIS CORP

Fundamental Rating

Overall RGS gets a fundamental rating of 3 out of 10. We evaluated RGS against 74 industry peers in the Diversified Consumer Services industry. There are concerns on the financial health of RGS while its profitability can be described as average. RGS is valued correctly, but it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

RGS had positive earnings in the past year.

In the past year RGS had a positive cash flow from operations.

In the past 5 years RGS reported 4 times negative net income.

RGS had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

RGS's Return On Assets of 19.22% is amongst the best of the industry. RGS outperforms 94.59% of its industry peers.

RGS has a better Return On Equity (143.12%) than 97.30% of its industry peers.

With a Return On Invested Capital value of 3.51%, RGS perfoms like the industry average, outperforming 59.46% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	19.22%
ROE	143.12%
ROIC	3.51%

ROA(3y)1.6%

ROA(5y)-3.87%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

RGS's Profit Margin of 49.34% is amongst the best of the industry. RGS outperforms 97.30% of its industry peers.

RGS has a Operating Margin of 9.15%. This is in the better half of the industry: RGS outperforms 63.51% of its industry peers.

RGS's Operating Margin has improved in the last couple of years.

The Gross Margin of RGS (101.72%) is better than 100.00% of its industry peers.

In the last couple of years the Gross Margin of RGS has grown nicely.

		Industry Rank	Sector Rank
OM	9.15%
PM (TTM)	49.34%
GM	101.73%

OM growth 3YN/A

OM growth 5Y92.69%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.74%

GM growth 5Y16.96%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so RGS is destroying value.

Compared to 1 year ago, RGS has about the same amount of shares outstanding.

RGS has less shares outstanding than it did 5 years ago.

RGS has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.44, we must say that RGS is in the distress zone and has some risk of bankruptcy.

RGS's Altman-Z score of 0.44 is on the low side compared to the rest of the industry. RGS is outperformed by 62.16% of its industry peers.

RGS has a debt to FCF ratio of 9.91. This is a negative value and a sign of low solvency as RGS would need 9.91 years to pay back of all of its debts.

RGS has a Debt to FCF ratio of 9.91. This is in the better half of the industry: RGS outperforms 63.51% of its industry peers.

RGS has a Debt/Equity ratio of 1.63. This is a high value indicating a heavy dependency on external financing.

The Debt to Equity ratio of RGS (1.63) is worse than 68.92% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.63
Debt/FCF	9.91
Altman-Z	0.44

ROIC/WACC0.29

WACC11.91%

2.3 Liquidity

A Current Ratio of 0.47 indicates that RGS may have some problems paying its short term obligations.

RGS has a Current ratio of 0.47. This is amonst the worse of the industry: RGS underperforms 83.78% of its industry peers.

RGS has a Quick Ratio of 0.47. This is a bad value and indicates that RGS is not financially healthy enough and could expect problems in meeting its short term obligations.

RGS has a worse Quick ratio (0.47) than 82.43% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.47
Quick Ratio	0.47

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

RGS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1934.03%, which is quite impressive.

RGS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 100.49% yearly.

RGS shows a decrease in Revenue. In the last year, the revenue decreased by -4.88%.

Measured over the past years, RGS shows a very negative growth in Revenue. The Revenue has been decreasing by -28.27% on average per year.

EPS 1Y (TTM)1934.03%

EPS 3YN/A

EPS 5Y100.49%

EPS Q2Q%108.41%

Revenue 1Y (TTM)-4.88%

Revenue growth 3Y-21%

Revenue growth 5Y-28.27%

Sales Q2Q%15.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-107.14%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-6.39%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 0.76, which indicates a rather cheap valuation of RGS.

Based on the Price/Earnings ratio, RGS is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.

When comparing the Price/Earnings ratio of RGS to the average of the S&P500 Index (27.20), we can say RGS is valued rather cheaply.

The Forward Price/Earnings Ratio is negative for RGS. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	0.76
Fwd PE	N/A

4.2 Price Multiples

RGS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. RGS is cheaper than 83.78% of the companies in the same industry.

Based on the Price/Free Cash Flow ratio, RGS is valued cheaper than 94.59% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	6.15
EV/EBITDA	7.77

4.3 Compensation for Growth

The decent profitability rating of RGS may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)0.01

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for RGS!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

REGIS CORP

NASDAQ:RGS (9/17/2025, 8:01:01 PM)

After market: 28.9162 +0.44 (+1.53%)

28.48

+0.03 (+0.11%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Services

GICS IndustryDiversified Consumer Services

Earnings (Last)08-26 2025-08-26/amc

Earnings (Next)11-04 2025-11-04

Inst Owners32.4%

Inst Owner Change-4.95%

Ins Owners10.8%

Ins Owner Change0.32%

Market Cap69.49M

Analysts80

Price TargetN/A

Short Float %4.5%

Short Ratio5.7

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	0.76
Fwd PE	N/A
P/S	0.35
P/FCF	6.15
P/OCF	5.75
P/B	1.01
P/tB	N/A
EV/EBITDA	7.77

EPS(TTM)37.35

EY131.14%

EPS(NY)-2.67

Fwd EYN/A

FCF(TTM)4.63

FCFY16.27%

OCF(TTM)4.95

OCFY17.38%

SpS81.6

BVpS28.13

TBVpS-49.83

PEG (NY)N/A

PEG (5Y)0.01

Profitability

		Industry Rank	Sector Rank
ROA	19.22%
ROE	143.12%
ROCE	4.44%
ROIC	3.51%
ROICexc	3.63%
ROICexgc	6.96%
OM	9.15%
PM (TTM)	49.34%
GM	101.73%
FCFM	5.68%

ROA(3y)1.6%

ROA(5y)-3.87%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5Y22.11%

ROICexc growth 3YN/A

ROICexc growth 5Y42.42%

OM growth 3YN/A

OM growth 5Y92.69%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.74%

GM growth 5Y16.96%

F-Score7

Asset Turnover0.39

Health

		Industry Rank	Sector Rank
Debt/Equity	1.63
Debt/FCF	9.91
Debt/EBITDA	5.17
Cap/Depr	22.58%
Cap/Sales	0.39%
Interest Coverage	250
Cash Conversion	55.78%
Profit Quality	11.51%
Current Ratio	0.47
Quick Ratio	0.47
Altman-Z	0.44

F-Score7

WACC11.91%

ROIC/WACC0.29

Cap/Depr(3y)33.16%

Cap/Depr(5y)56.96%

Cap/Sales(3y)0.77%

Cap/Sales(5y)2.22%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)1934.03%

EPS 3YN/A

EPS 5Y100.49%

EPS Q2Q%108.41%

EPS Next Y-107.14%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-4.88%

Revenue growth 3Y-21%

Revenue growth 5Y-28.27%

Sales Q2Q%15.81%

Revenue Next Year-6.39%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-9.36%

EBIT growth 3YN/A

EBIT growth 5Y38.21%

EBIT Next Year66.39%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y179.9%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y194.71%

OCF growth 3YN/A

OCF growth 5YN/A

REGIS CORP (RGS) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens